APPLICATION OF QUATERNARY PYRIDINIUM SALTS AS VASOPROTECTIVE AGENTS Russian patent published in 2009 - IPC A61K31/4425 A61P3/10 A61P3/04 A61P1/04 A61P9/10 

Abstract RU 2366420 C2

FIELD: medicine.

SUBSTANCE: there is offered application of quaternary pyridinium salts of formula (1) , MNA+ where R is NH2, CH3, N(H)CH2OH group, X is a counterion, for preparing a vasoprotective agent for treatment (prevention) of conditions (diseases) associated with vascular endothelium dysfunction, oxidising stress, and/or insufficient production of endothelial prostacyclin PGI2 where the specified condition (disease) is atherosclerosis, dislipidemy, hypercholesterolemia or hypertriglyceridemia, low blood plasma level of HDL, or thrombosis not associated directly with atherosclerosis, or disease is chosen from group including: pulmonary hypertension, chronic obstructive pulmonary disease, gastric or duodenal ulcer, chronic liver disease; also application for manufacturing of dietary supplement of said application, the related method of treatment (prevention), and the method for increasing prostacyclin levels.

EFFECT: shown antiatherogenic and thrombolytic action of MNA+, higher blood level of HDL.

49 cl, 10 dwg

Similar patents RU2366420C2

Title Year Author Number
USE OF QUARTENARY PYRIDINIUM COMPOUNDS FOR VASOPROTECTION AND/OR HEPATOPROTECTION 2008
  • Gebitskij Ezhi
  • Martsinek Andzhej
  • Khlopitskij Stefan
  • Adamus Jan
RU2477132C2
NEW APPLICATION OF THERAPEUTICALLY EFFECTIVE PEPTIDES 2006
  • Jaukhiajnen Tiina
  • Korpela Riitta
  • Vapaatalo Khejkki
  • Rennbak Mats
RU2457852C2
FOOD PRODUCT FOR DIABETICS 2005
  • Shul'Man Avidor
  • Pelled Dori
  • Kouehn Tsafra
RU2380983C2
SYNTHESIS AND USE OF TETRAHYDROPYROLLO[3,2-c]PYRIDIN-4-ONE DERIVATIVES TO TREAT OBESITY, PSYCHIATRIC AND NEUROLOGICAL DISORDERS 2006
  • Cheng Lejfeng
RU2415856C2
INHIBITORS OF NO-SYNTHASE BASED ON MERCAPTO- AND SELENODERIVATIVES 1996
  • Sazan Garri Dzh.
  • Zal'Tsman Ehndrju L.
  • Sabo Ksaba
RU2191575C2
COMBINATION OF DIPEPTIDILPEPTIDASE IV (DPP IV) INHIBITOR AND CARDIOVASCULAR SUBSTANCE 2003
  • Olme David Grenvill'
  • Shetti Suraj Shivappa
  • Kh'Juz Tomas Ehduard
RU2336876C2
METHOD OF TREATING METABOLIC SYNDROME WITH USING DOPAMINE RECEPTOR AGONISTS 2008
  • Kinkotta Ehntoni Kh.
RU2473344C2
METHOD FOR METABOLIC SYNDROME TREATMENT USING DOPAMINE RECEPTOR AGONISTS 2012
  • Kinkotta Entoni Kh.
RU2624232C2
COMPOSITION POSSESSING ENDOTHELIAL PROTECTIVE, VASODILATING AND ANGIOPROTECTIVE EFFECT 2011
  • Pokrovskij Mikhail Vladimirovich
  • Nesteruk Vladimir Viktorovich
  • Strekalov Anton Evgen'Evich
RU2464019C1
DERIVATIVES OF BENZIMIDAZOLE AND ITS APPLICATION 2005
  • Kuroita Takanobu
  • Sakamoto Khiroki
  • Odzima Mami
RU2369608C2

RU 2 366 420 C2

Authors

Gembitskij Ezhi

Khlopitskij Stefan

Dates

2009-09-10Published

2005-01-07Filed